Brooks W Morgan1, Matthew R Grigsby1, Trishul Siddharthan1, Muhammad Chowdhury2, Adolfo Rubinstein3, Laura Gutierrez3, Vilma Irazola3, J Jaime Miranda4, Antonio Bernabe-Ortiz5, Dewan Alam6, Robert A Wise1, William Checkley7. 1. Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, Md; Center for Global Non-Communicable Diseases, School of Medicine, Johns Hopkins University, Baltimore, Md. 2. Noncommunicable Diseases, Health Systems and Population Studies Division, icddr,b, Dhaka, Bangladesh. 3. Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina. 4. CRONICAS Centre of Excellence for Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru; Department of Medicine, School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru. 5. CRONICAS Centre of Excellence for Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru. 6. School of Kinesiology and Health Science, Faculty of Health, York University, Toronto, Ontario, Canada. 7. Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, Md; Center for Global Non-Communicable Diseases, School of Medicine, Johns Hopkins University, Baltimore, Md. Electronic address: wcheckl1@jhmi.edu.
Abstract
BACKGROUND: Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) represents the confluence of bronchial airway hyperreactivity and chronic airflow limitation and has been described as leading to worse lung function and quality of life than found with either singular disease process. OBJECTIVE: We aimed to describe the prevalence and risk factors for ACO among adults across 6 low- and middle-income countries (LMICs). METHODS: We compiled cross-sectional data for 11,923 participants aged 35 to 92 years from 4 population-based studies in 12 settings. We defined COPD as postbronchodilator FEV1/forced vital capacity ratio below the lower limit of normal, asthma as wheeze or medication use in 12 months or self-reported physician diagnosis, and ACO as having both. RESULTS: The prevalence of ACO was 3.8% (0% in rural Puno, Peru, to 7.8% in Matlab, Bangladesh). The odds of having ACO were higher with household exposure to biomass fuel smoke (odds ratio [OR], 1.48; 95% CI, 0.98-2.23), smoking tobacco (OR, 1.28 per 10 pack-years; 95% CI, 1.22-1.34), and having primary or less education (OR, 1.35; 95% CI, 1.07-1.70) as compared to nonobstructed nonasthma individuals. ACO was associated with severe obstruction (FEV1 %, <50; 31.6% of ACO vs 10.9% of COPD alone) and severe spirometric deficits compared with participants with asthma (-1.61 z scores FEV1; 95% CI, -1.48 to -1.75) or COPD alone (-0.94 z scores; 95% CI, -0.78 to -1.10). CONCLUSIONS: ACO may be as prevalent and more severe in LMICs than has been reported in high-income settings. Exposure to biomass fuel smoke may be an overlooked risk factor, and we favor diagnostic criteria for ACO that include environmental exposures common to LMICs.
BACKGROUND:Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) represents the confluence of bronchial airway hyperreactivity and chronic airflow limitation and has been described as leading to worse lung function and quality of life than found with either singular disease process. OBJECTIVE: We aimed to describe the prevalence and risk factors for ACO among adults across 6 low- and middle-income countries (LMICs). METHODS: We compiled cross-sectional data for 11,923 participants aged 35 to 92 years from 4 population-based studies in 12 settings. We defined COPD as postbronchodilator FEV1/forced vital capacity ratio below the lower limit of normal, asthma as wheeze or medication use in 12 months or self-reported physician diagnosis, and ACO as having both. RESULTS: The prevalence of ACO was 3.8% (0% in rural Puno, Peru, to 7.8% in Matlab, Bangladesh). The odds of having ACO were higher with household exposure to biomass fuel smoke (odds ratio [OR], 1.48; 95% CI, 0.98-2.23), smoking tobacco (OR, 1.28 per 10 pack-years; 95% CI, 1.22-1.34), and having primary or less education (OR, 1.35; 95% CI, 1.07-1.70) as compared to nonobstructed nonasthma individuals. ACO was associated with severe obstruction (FEV1 %, <50; 31.6% of ACO vs 10.9% of COPD alone) and severe spirometric deficits compared with participants with asthma (-1.61 z scores FEV1; 95% CI, -1.48 to -1.75) or COPD alone (-0.94 z scores; 95% CI, -0.78 to -1.10). CONCLUSIONS:ACO may be as prevalent and more severe in LMICs than has been reported in high-income settings. Exposure to biomass fuel smoke may be an overlooked risk factor, and we favor diagnostic criteria for ACO that include environmental exposures common to LMICs.
Authors: Prescott G Woodruff; Maarten van den Berge; Richard C Boucher; Christopher Brightling; Esteban G Burchard; Stephanie A Christenson; MeiLan K Han; Michael J Holtzman; Monica Kraft; David A Lynch; Fernando D Martinez; Helen K Reddel; Don D Sin; George R Washko; Sally E Wenzel; Antonello Punturieri; Michelle M Freemer; Robert A Wise Journal: Am J Respir Crit Care Med Date: 2017-08-01 Impact factor: 21.405
Authors: Marc Miravitlles; Joan B Soriano; Julio Ancochea; Luis Muñoz; Enric Duran-Tauleria; Guadalupe Sánchez; Víctor Sobradillo; Francisco García-Río Journal: Respir Med Date: 2013-04-16 Impact factor: 3.415
Authors: Thomas E Sussan; Vijendra Ingole; Jung-Hyun Kim; Sarah McCormick; Jesse Negherbon; Jonathan Fallica; Jason Akulian; Lonny Yarmus; David Feller-Kopman; Marsha Wills-Karp; Maureen R Horton; Patrick N Breysse; Anurag Agrawal; Sanjay Juvekar; Sundeep Salvi; Shyam Biswal Journal: Am J Respir Cell Mol Biol Date: 2014-03 Impact factor: 6.914
Authors: J Jaime Miranda; Antonio Bernabe-Ortiz; Liam Smeeth; Robert H Gilman; William Checkley Journal: BMJ Open Date: 2012-01-11 Impact factor: 2.692
Authors: Trishul Siddharthan; Adaeze C Wosu; Suzanne L Pollard; Shakir Hossen; Patricia Alupo; Timothy Shade; Robert Kalyesubula; Shumonta Quaderi; Robert A Wise; John R Hurst; Bruce Kirenga; William Checkley Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-11-03